Maravai Lifesciences Holdings (MRVI) Other Non-Current Assets (2020 - 2026)

Maravai Lifesciences Holdings' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $40.2 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 30.13% year-over-year to $40.2 million in Q1 2026; TTM through Mar 2026 was $40.2 million, a 30.13% decrease from a year earlier, with the FY2025 full-year figure at $41.9 million, down 29.96% from the prior year.
• Other Non-Current Assets fell to $40.2 million in Q1 2026 per MRVI's latest filing, from $41.9 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $127.0 million in Q1 2023 and bottomed at $40.2 million in Q1 2026.
• The 5-year median for Other Non-Current Assets is $64.2 million (2022), against an average of $71.9 million.
• Biggest YoY gain for Other Non-Current Assets was 2028.57% in 2022; the steepest drop was 42.08% in 2022.
• Year by year, Other Non-Current Assets stood at $115.6 million in 2022, then tumbled by 32.85% to $77.6 million in 2023, then dropped by 22.97% to $59.8 million in 2024, then retreated by 29.96% to $41.9 million in 2025, then declined by 3.92% to $40.2 million in 2026.
• Per Business Quant, the three latest MRVI Other Non-Current Assets figures stand at $40.2 million (Q1 2026), $41.9 million (Q4 2025), and $49.4 million (Q3 2025).